Surgical management of a hand extravasation of anthracycline at late presentation

Abstract - 166 PDF - 59
Komla Sena Amouzou, Nabil Berny, Tiemoko Moulaye Haidara, Abdessamad Chlihi, Mohamed Ezzoubi

Abstract


Anthracycline extravasation remains a feared serious complication of chemotherapy. At late presentation, deep ulceration and extensive soft tissue damage are seen. Hand extravasation of anthracycline may lead to tendon and nerves destruction with functional and economical impairments. We report a case of Epirubicin extravasation seen at day 25 in a 46-year-old woman treated for breast cancer. A groin flap failed due to the persistence of anthracyclin in the wound. A split thickness skin graft was done after all the tendons were removed. The chemotherapy was interrupted for two months. Wide serial debridements are needed to achieve the removal of all molecules of anthracycline that are observed when granulating tissue is observed permanently in the wound.

 


Keywords


Anthracycline; chemotherapy; debridement; extravasation; hand

Full Text:

PDF

References


Langer SW, Sehested M, Jensen PB. Anthracycline extravasation: A comprehensive review of experimental and clinical treatments. Tumori 2009; 95(3): 273–282.

Langer SW. Dexrazoxane for the treatment of chemotherapy related side effects. Cancer Manag Res 2014; 6: 357–363. doi: 10.2147/CMAR.S47238.

Dinoi GL, Saibene G, Re B, Balzarini A, et. al. Cytotoxic extravasation: An issue disappearing or a problem without solution? Tumori 2016; 102(3): 290–293. doi: 10.5301/tj.5000486.

Arroyo PA, Perez RU, Feijoo MAF, Hernandez MAC. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation. J Can Res Ther 2010; 6(4): 573– 574. doi: 10.4103/0973-1482.77081.

Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016; 7(1): 87–97. doi: 10.53 06/wjco.v7.i1.87.

Schrijvers DL. Extravasation: A dreaded complicati- on of chemotherapy. Ann Oncol 2003; 14(3): 26–30. doi: 10.1093/annonc/mdg744.

Dahlstrom KK, Chenoufi HL, Daugaard S. Fluorescence

microscopic demonstration and demarcation of

doxorubicin extravasation experimental and clinical

studies. Cancer 2006; 65(8): 1722–1726. doi: 10.10

/1097-0142(19900415)65:8<1722::AID-CNCR282065

>3.0.CO;2-E.


Refbacks

  • There are currently no refbacks.